Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Brian C. Thomas
|
| gptkbp:collaboratesWith |
gptkb:Moderna
|
| gptkbp:focus |
CRISPR technology
gene editing |
| gptkbp:foundedYear |
2018
|
| gptkbp:founder |
Brian C. Thomas
|
| gptkbp:fundedBy |
gptkb:Pivotal_bioVenture_Partners
gptkb:RA_Capital_Management gptkb:Leaps_by_Bayer gptkb:SymBiosis gptkb:Sofinnova_Investments gptkb:Novo_Holdings private |
| gptkbp:headquartersLocation |
gptkb:Emeryville,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Metagenomi
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:platform |
metagenomics-based discovery
|
| gptkbp:product |
novel gene editing systems
|
| gptkbp:researchArea |
therapeutics
genome editing |
| gptkbp:website |
https://www.metagenomi.co/
|
| gptkbp:bfsParent |
gptkb:Fine_Structure_Ventures
|
| gptkbp:bfsLayer |
7
|